Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 21, 2026 20:49 UTC |
YARNO WENDY LDirector
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001181186-26-000002 · wk-form4_1779396584.xml · derivative · entry 2 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:49 UTC |
YARNO WENDY LDirector
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001181186-26-000002 · wk-form4_1779396584.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:32 UTC |
Shepard JayDirector
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001587788-26-000002 · wk-form4_1779395521.xml · derivative · entry 2 Shepard Jay · CIK 0001587788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:32 UTC |
Shepard JayDirector
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001587788-26-000002 · wk-form4_1779395521.xml · derivative · entry 1 Shepard Jay · CIK 0001587788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:11 UTC |
Weiner David B.Director
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001669080-26-000003 · wk-form4_1779394282.xml · derivative · entry 2 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:11 UTC |
Weiner David B.Director
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001669080-26-000003 · wk-form4_1779394282.xml · derivative · entry 1 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:11 UTC |
Miller Ann CalbyDirector
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001771423-26-000001 · wk-form4_1779394312.xml · derivative · entry 2 Miller Ann Calby · CIK 0001771423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:11 UTC |
Miller Ann CalbyDirector
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001771423-26-000001 · wk-form4_1779394312.xml · derivative · entry 1 Miller Ann Calby · CIK 0001771423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:10 UTC |
Zoth Lota S.Director
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001278219-26-000001 · wk-form4_1779394245.xml · derivative · entry 2 Zoth Lota S. · CIK 0001278219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:10 UTC |
Zoth Lota S.Director
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001278219-26-000001 · wk-form4_1779394245.xml · derivative · entry 1 Zoth Lota S. · CIK 0001278219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:06 UTC |
DANSEY ROGER DDirector
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001741836-26-000005 · wk-form4_1779394006.xml · derivative · entry 2 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:06 UTC |
DANSEY ROGER DDirector
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001741836-26-000005 · wk-form4_1779394006.xml · derivative · entry 1 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Humeau LaurentChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 27,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001770390-26-000005 · wk-form4_1779393944.xml · derivative · entry 5 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,440 Underlying: Common Stock · 27,440 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F6 · date: The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Humeau LaurentChief Scientific Officer
|
GrantCommon Stock Option · Derivative | 34,160 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001770390-26-000005 · wk-form4_1779393944.xml · derivative · entry 4 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,160 Underlying: Common Stock · 34,160 shares Expires 2036-05-20 F3 · date: The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F4 · derivative.exercise_date: The vesting schedule for the options granted on May 20, 2026 was as follows: 11,387 shares will vest on February 26, 2027; 11,387 shares will vest on February 26, 2028; 11,386 shares will vest on February 26, 2029. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001770390-26-000005 · wk-form4_1779393944.xml · derivative · entry 3 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,054 Underlying: Common Stock · 6,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Humeau LaurentChief Scientific Officer
|
Tax withholdingCommon Stock | 2,163 | $1.23 | $2,660.49 |
DisclosureSEC source: 0001770390-26-000005 · wk-form4_1779393944.xml · nonDerivative · entry 2 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,823 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionCommon Stock | 6,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001770390-26-000005 · wk-form4_1779393944.xml · nonDerivative · entry 1 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:06 UTC |
BENITO SIMON XDirector
|
GrantRestricted Stock Unit · Derivative | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001273306-26-000001 · wk-form4_1779393978.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:06 UTC |
BENITO SIMON XDirector
|
GrantCommon Stock Options · Derivative | 41,800 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001273306-26-000001 · wk-form4_1779393978.xml · derivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,800 Underlying: Common Stock · 41,800 shares Expires 2036-05-20 F1 · shares: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest 100% on May 20, 2027. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Sumner Michael JohnChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 37,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000006 · wk-form4_1779393902.xml · derivative · entry 5 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,684 Underlying: Common Stock · 37,684 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F6 · date: The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Sumner Michael JohnChief Medical Officer
|
GrantCommon Stock Option · Derivative | 46,876 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001936799-26-000006 · wk-form4_1779393902.xml · derivative · entry 4 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,876 Underlying: Common Stock · 46,876 shares Expires 2036-05-20 F3 · date: The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F4 · derivative.exercise_date: The vesting schedule for the options granted on May 20, 2026 was as follows: 15,626 shares will vest on February 26, 2027; 15,625 shares will vest on February 26, 2028; 15,625 shares will vest on February 26, 2029. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000006 · wk-form4_1779393902.xml · derivative · entry 3 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,900 Underlying: Common Stock · 9,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Sumner Michael JohnChief Medical Officer
|
Tax withholdingCommon Stock | 2,693 | $1.23 | $3,312.39 |
DisclosureSEC source: 0001936799-26-000006 · wk-form4_1779393902.xml · nonDerivative · entry 2 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,038 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:05 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionCommon Stock | 9,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001936799-26-000006 · wk-form4_1779393902.xml · nonDerivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 100,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001771498-26-000005 · wk-form4_1779393839.xml · derivative · entry 5 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,240 Underlying: Common Stock · 100,240 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F6 · date: The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantCommon Stock Option · Derivative | 123,760 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001771498-26-000005 · wk-form4_1779393839.xml · derivative · entry 4 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,760 Underlying: Common Stock · 123,760 shares Expires 2036-05-20 F3 · date: The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F4 · derivative.exercise_date: The vesting schedule for the options granted on May 20, 2026 was as follows: 41,254 shares will vest on February 26, 2027; 41,253 shares will vest on February 26, 2028; 41,253 shares will vest on February 26, 2029. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 28,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001771498-26-000005 · wk-form4_1779393839.xml · derivative · entry 3 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,592 Underlying: Common Stock · 28,296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 12,306 | $1.23 | $15,136.38 |
DisclosureSEC source: 0001771498-26-000005 · wk-form4_1779393839.xml · nonDerivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,021 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 28,296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001771498-26-000005 · wk-form4_1779393839.xml · nonDerivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
KIES PETERCFO
|
GrantRestricted Stock Unit · Derivative | 32,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001259780-26-000006 · wk-form4_1779393868.xml · derivative · entry 6 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,480 Underlying: Common Stock · 32,480 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F6 · date: The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
KIES PETERCFO
|
GrantCommon Stock Option · Derivative | 39,760 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001259780-26-000006 · wk-form4_1779393868.xml · derivative · entry 5 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,760 Underlying: Common Stock · 39,760 shares Expires 2036-05-20 F3 · date: The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. F4 · derivative.exercise_date: The vesting schedule for the options granted on May 20, 2026 was as follows: 13,254 shares will vest on February 26, 2027; 13,253 shares will vest on February 26, 2028; 13,253 shares will vest on February 26, 2029. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
KIES PETERCFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001259780-26-000006 · wk-form4_1779393868.xml · derivative · entry 4 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,400 Underlying: Common Stock · 8,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
KIES PETERCFO
|
Tax withholdingCommon Stock | 4,688 | $1.23 | $5,766.24 |
DisclosureSEC source: 0001259780-26-000006 · wk-form4_1779393868.xml · nonDerivative · entry 2 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,854 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:04 UTC |
KIES PETERCFO
|
Exercise / conversionCommon Stock | 8,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001259780-26-000006 · wk-form4_1779393868.xml · nonDerivative · entry 1 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:08 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001771498-26-000004 · wk-form4_1779134885.xml · derivative · entry 3 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,744 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:08 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 7,717 | $1.30 | $10,032.10 |
DisclosureSEC source: 0001771498-26-000004 · wk-form4_1779134885.xml · nonDerivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,031 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:08 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 17,744 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001771498-26-000004 · wk-form4_1779134885.xml · nonDerivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:07 UTC |
KIES PETERCFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001259780-26-000005 · wk-form4_1779134848.xml · derivative · entry 4 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:07 UTC |
KIES PETERCFO
|
Tax withholdingCommon Stock | 2,571 | $1.30 | $3,342.30 |
DisclosureSEC source: 0001259780-26-000005 · wk-form4_1779134848.xml · nonDerivative · entry 2 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,842 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:07 UTC |
KIES PETERCFO
|
Exercise / conversionCommon Stock | 4,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001259780-26-000005 · wk-form4_1779134848.xml · nonDerivative · entry 1 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:06 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001770390-26-000004 · wk-form4_1779134799.xml · derivative · entry 3 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:06 UTC |
Humeau LaurentChief Scientific Officer
|
Tax withholdingCommon Stock | 1,712 | $1.30 | $2,225.60 |
DisclosureSEC source: 0001770390-26-000004 · wk-form4_1779134799.xml · nonDerivative · entry 2 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,959 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:06 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionCommon Stock | 4,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001770390-26-000004 · wk-form4_1779134799.xml · nonDerivative · entry 1 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:04 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000005 · wk-form4_1779134693.xml · derivative · entry 3 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,385 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:04 UTC |
Sumner Michael JohnChief Medical Officer
|
Tax withholdingCommon Stock | 680 | $1.30 | $884.00 |
DisclosureSEC source: 0001936799-26-000005 · wk-form4_1779134693.xml · nonDerivative · entry 2 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,281 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:04 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionCommon Stock | 2,385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001936799-26-000005 · wk-form4_1779134693.xml · nonDerivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:05 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000004 · wk-form4_1775077509.xml · derivative · entry 3 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:05 UTC |
Sumner Michael JohnChief Medical Officer
|
Tax withholdingCommon Stock | 1,223 | $1.74 | $2,128.02 |
DisclosureSEC source: 0001936799-26-000004 · wk-form4_1775077509.xml · nonDerivative · entry 2 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,576 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:05 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionCommon Stock | 4,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001936799-26-000004 · wk-form4_1775077509.xml · nonDerivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:55 UTC |
Humeau LaurentChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 21,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001770390-26-000003 · wk-form4_1772747737.xml · derivative · entry 2 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,560 Underlying: Common Stock · 21,560 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.